What is the average price target for 89BIO INC (ETNB) stock?
11 analysts have analysed ETNB and the average price target is 29.52 USD. This implies a price increase of 98.9% is expected in the next year compared to the current price of 14.84.
89BIO INC (ETNB) Forecast, Price Target & Analyst Ratings
NASDAQ:ETNB • US2825591033
Current stock price
14.84 USD
0 (0%)
At close:
14.95 USD
+0.11 (+0.74%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 89BIO INC (ETNB).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Feb 25, 2026
- Period
- Q3 / 2025
- EPS Estimate
- -$0.51
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$29.52
Upside
+ 98.90%
From current price of $14.84 to mean target of $29.52, Based on 11 analyst forecasts
Low
$14.65
Median
$29.07
High
$57.75
Price Target Revisions
1 Month
0.00%
3 Months
-1.76%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for ETNB. The average price target is 29.52 USD. This implies a price increase of 98.9% is expected in the next year compared to the current price of 14.84.
The average price target has been revised downward by 1.76% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
ETNB was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ETNB.
In the previous month the buy percentage consensus was at a similar level.
ETNB was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-09-19 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-09-19 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-09-19 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-08-25 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-03-14 | Goldman Sachs | Initiate | Neutral |
| 2025-03-13 | Citigroup | Initiate | Buy |
| 2025-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-04 | Wolfe Research | Initiate | Outperform |
| 2025-01-31 | UBS | Maintains | Buy -> Buy |
| 2025-01-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-08-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-06 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-12 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-17 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Feb 25, 2026
- Period
- Q3 / 2025
- EPS Estimate
- -$0.51
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 63.02%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-1.31%
EPS (3 Months)
3.49%
Next Earnings Summary
ETNB is expected to report earnings on 2/25/2026. The consensus EPS estimate for the next earnings is -0.51 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2025 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 267.77% | N/A 195.14% | N/A 120.10% | N/A 46.43% | N/A 31.96% | ||||||||
| EBITDA YoY % growth | -15.15M | -26.62M -75.71% | -49.3M -85.20% | -89.66M -81.87% | -102.18M -13.96% | -151.154M -47.93% | -384.618M -154.45% | N/A 5.61% | N/A -7.76% | N/A -11.66% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.16M | -26.64M -75.73% | -49.36M -85.29% | -89.74M -81.81% | -102.25M -13.94% | -151.204M -47.88% | -384.656M -154.40% | N/A 6.45% | N/A -10.35% | N/A -5.53% | N/A 12.90% | N/A 59.44% | N/A 220.22% | N/A 193.26% | N/A 72.28% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | -3.10 78.22% | -4.48 -44.52% | -3.54 20.98% | -2.01 43.22% | -3.43 -70.65% | N/A 34.68% | N/A -8.27% | N/A 7.81% | N/A 31.13% | N/A 60.26% | N/A 199.17% | N/A 244.54% | N/A 63.90% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 63.02% | -0.54 47.40% | -0.59 -19.69% | -0.59 16.32% | -0.64 -24.01% | -0.61 -14.07% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | -84.532M 44.35% | -88.421M 27.50% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -84.472M 44.40% | -88.145M 27.75% | -96.989M -27.77% | -100.896M 12.89% | -117.251M -38.80% | -112.164M -27.25% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
10.47%
EPS Next 5 Year
12.74%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-6.97%
EBIT Next 5 Year
N/A
89BIO INC / ETNB Forecast FAQ
Can you provide the upcoming earnings date for 89BIO INC?
89BIO INC (ETNB) will report earnings on 2026-02-25, after the market close.
Can you provide the consensus estimates for 89BIO INC next earnings?
The consensus EPS estimate for the next earnings of 89BIO INC (ETNB) is -0.51 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for 89BIO INC stock?
The number of analysts covering 89BIO INC (ETNB) is 11.